As aforementioned in Section 5, a phase 1 study of IT SD-101 in combination with anti-OX40 antibody BMS 986178 and local low-dose irradiation is ongoing for patients with low-grade B-cell NHL (NCT03410901). The gene discussed is TNFRSF4; the disease is B-cell non-Hodgkin lymphoma.